# H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

> **NCT00992433** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 192 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated Influenza H1N1 vaccine

## Key facts

- **NCT ID:** NCT00992433
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00992433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00992433, "H1N1 Vaccine at Two Dose Levels in HIV Positive Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00992433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*